Figure 5.
Rac2 deficiency decreases mortality in bleomycin-induced pulmonary fibrosis. Survival curves shown over 21 days for WT and rac2-/- mice receiving BLM or saline (n = 13-22 per group).
Rac2 deficiency decreases mortality in bleomycin-induced pulmonary fibrosis. Survival curves shown over 21 days for WT and rac2-/- mice receiving BLM or saline (n = 13-22 per group).